|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,196.00 INR | +0.18% |
|
-1.77% | +7.90% |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 62TCr 646.21Cr 568.09Cr 528.82Cr 485.65Cr 911.94Cr 923.96Cr 6.29TCr 2.45TCr 31TCr 2.43TCr 2.37TCr 1,05800Cr | P/E 2026 |
44.2x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 58TCr 605.24Cr 532.07Cr 495.29Cr 454.86Cr 854.11Cr 865.37Cr 5.89TCr 2.3TCr 29TCr 2.27TCr 2.22TCr 99TCr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.49x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.18% | ||
| 1 week | -1.77% | ||
| Current month | -0.38% | ||
| 1 month | +1.93% | ||
| 3 months | -4.50% | ||
| 6 months | +11.60% | ||
| Current year | +7.90% |
| 1 week | 2,166 |  | 2,249.3 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.18% | -1.77% | +2.36% | +172.36% | 642.34Cr | |
| +1.68% | +2.13% | +16.17% | +77.49% | 4.84TCr | |
| +1.52% | +2.95% | +60.39% | +112.28% | 3.58TCr | |
| -0.09% | -0.66% | -8.03% | +31.90% | 1.18TCr | |
| -0.05% | -3.10% | +13.50% | +77.95% | 1.15TCr | |
| -0.93% | -0.37% | +37.53% | +142.08% | 901.45Cr | |
| +0.18% | +0.58% | +49.62% | -9.13% | 698.99Cr | |
| +0.95% | -1.59% | +12.34% | +32.81% | 669.73Cr | |
| +3.51% | -10.57% | -31.55% | +0.09% | 529.99Cr | |
| +0.49% | -0.97% | +21.61% | +124.86% | 436.97Cr | |
| Average | +0.74% | -1.23% | +17.39% | +76.27% | 1.46TCr | |
| Weighted average by Cap. | +1.06% | -0.18% | +25.39% | +82.92% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 159.66Cr 140.36Cr 130.65Cr 119.99Cr 225.31Cr 228.28Cr 1.55TCr 606.55Cr 7.56TCr 599.35Cr 586.43Cr 26TCr | 17TCr 173.85Cr 152.83Cr 142.26Cr 130.65Cr 245.33Cr 248.57Cr 1.69TCr 660.45Cr 8.23TCr 652.61Cr 638.54Cr 28TCr |
| Net income | 2.05TCr 21Cr 19Cr 18Cr 16Cr 30Cr 31Cr 208.25Cr 81Cr 1.01TCr 80Cr 79Cr 3.5TCr | 2.33TCr 24Cr 21Cr 20Cr 18Cr 34Cr 35Cr 236.15Cr 92Cr 1.15TCr 91Cr 89Cr 3.97TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -34Cr -31Cr -58Cr -59Cr -398.56Cr -155.66Cr -1.94TCr -153.81Cr -150.5Cr -6.71TCr | -3.71TCr -39Cr -34Cr -32Cr -29Cr -55Cr -55Cr -376.53Cr -147.06Cr -1.83TCr -145.31Cr -142.18Cr -6.34TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | ₹2,196.00 | +0.18% | 5,93,586 |
| 24/26/24 | ₹2,192.00 | -0.59% | 4,29,562 |
| 23/26/23 | ₹2,205.10 | +0.24% | 5,67,718 |
| 22/26/22 | ₹2,199.90 | -1.88% | 9,42,175 |
| 21/26/21 | ₹2,242.10 | +0.12% | 2,74,753 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
